Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug 25:11:422.
doi: 10.3389/fnhum.2017.00422. eCollection 2017.

White Matter Injury after Intracerebral Hemorrhage: Pathophysiology and Therapeutic Strategies

Affiliations
Review

White Matter Injury after Intracerebral Hemorrhage: Pathophysiology and Therapeutic Strategies

Chuanyuan Tao et al. Front Hum Neurosci. .

Abstract

Intracerebral hemorrhage (ICH) accounts for 10%-30% of all types of stroke. Bleeding within the brain parenchyma causes gray matter (GM) destruction as well as proximal or distal white matter (WM) injury (WMI) due to complex pathophysiological mechanisms. Because WM has a distinct cellular architecture, blood supply pattern and corresponding function, and its response to stroke may vary from that of GM, a better understanding of the characteristics of WMI following ICH is essential and may shed new light on treatment options. Current evidence using histological, radiological and chemical biomarkers clearly confirms the spatio-temporal distribution of WMI post- ICH. Although certain types of pathological damage such as inflammatory, oxidative and neuro-excitotoxic injury to WM have been identified, the exact molecular mechanisms remain unclear. In this review article, we briefly describe the constitution and physiological function of brain WM, summarize evidence regarding WMI, and focus on the underlying pathophysiological mechanisms and therapeutic strategies.

Keywords: axonal damage; demyelination; intracerebral hemorrhage; pathophysiology; treatment; white matter injury.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The possible pathophysiological mechanisms of WMI following ICH. The pathophysiology of WMI is summarized according to the available literature. ICH causes WMI via primary and secondary injury. Mass effect during hematoma formation and mechanical barotrauma mechanism are responsible for the primary WMI. Later on, secondary cascades including neuroinflammation characterized by inflammatory cell infiltration and cytokines and chemokines release, oxidative stress induced by hemoglobin and its metabolites, and glutamate-mediated neuro-excitotoxicity further deteriorate WMI. Although the detailed molecular mechanisms remain unclear, MMP-9 and JNK mediated events play important roles. The final consequences are disintegration of WM with demyelination and axonal damage. ICH, intracerebral hemorrhage; WMI, white matter injury; MMP-9, matrix metalloproteinase 9; JNK, Jun N-terminal kinase.
Figure 2
Figure 2
The potential therapeutic and diagnostic strategies. MSH, morphogen Sonic hedgehog; MAG, myelin-associated glycoprotein; OMGP, oligodendrocyte myelin glycoprotein; DGF10, differentiation factor 10; GPCR, cell-type-specific G protein-coupled receptor; BDNF, brain-derived neurotrophic factor; LIF, leukemia inhibitory factor-like protein; STAT 3, signal transducer and activator of transcription 3; CNTF, ciliary neurotrophic factor; TNFR2, tumor necrosis factor receptor 2; GM, gray matter; WM, white matter; MRS, Magnetic resonance spectroscopy; CEST, Chemical Exchange Saturation Transfer; CMD, cerebral microdialysis. ↓ downregulate; ↑ upregulate; M1→M2, switch from pro-inflammatory M1 and the late anti-inflammatory M2.

Similar articles

Cited by

References

    1. Acheson A., Wijtenburg S. A., Rowland L. M., Bray B. C., Gaston F., Mathias C. W., et al. . (2014). Combining diffusion tensor imaging and magnetic resonance spectroscopy to study reduced frontal white matter integrity in youths with family histories of substance use disorders. Hum. Brain Mapp. 35, 5877–5887. 10.1002/hbm.22591 - DOI - PMC - PubMed
    1. Al-Chalabi A., Miller C. C. (2003). Neurofilaments and neurological disease. Bioessays 25, 346–355. 10.1002/bies.10251 - DOI - PubMed
    1. Arai K., Lo E. H. (2009). Oligovascular signaling in white matter stroke. Biol. Pharm. Bull. 32, 1639–1644. 10.1248/bpb.32.1639 - DOI - PMC - PubMed
    1. Berger R. P., Bazaco M. C., Wagner A. K., Kochanek P. M., Fabio A. (2010). Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury. Dev. Neurosci. 32, 396–405. 10.1159/000316803 - DOI - PMC - PubMed
    1. Bitsch A., Horn C., Kemmling Y., Seipelt M., Hellenbrand U., Stiefel M., et al. . (2002). Serum tau protein level as a marker of axonal damage in acute ischemic stroke. Eur. Neurol. 47, 45–51. 10.1159/000047946 - DOI - PubMed

LinkOut - more resources